FDA Investigator Jennifer L Custodio
Jennifer L Custodio has conducted inspections on 124 sites in 1 countries as of 02 Mar 2020. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
124
Last Inspection Date:
02 Mar 2020
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Jennifer L Custodio:
Adetutu M Gidado,
Affiong Flores,
Alice S Tsao,
Amy A Johnson,
Amy Kim,
Amy Wyan Mai,
Ana Djurdjevic,
Ana S Cabrera,
Andrew F Cohen,
Andrew J Molesky,
Angela Jourdain,
Anthony N Onianwa,
Anthony R Rauert,
Arsen Karapetyan,
Ashley Polizzotto,
Ayorinde O Babalola,
Billi Jom Johnson,
Brian M Brodman,
Byungja E Marciante,
Camilla S Smith,
Carrie E Jolly,
Charisse K Green,
Charles J Chacko,
Christian Parra,
Christina N Maurino,
Christine M Rivera,
Christopher J Adams,
Christopher S Fields,
Cordelia J Brammer,
Dale A Nyberg,
David H Smith,
David J Leray,
Dawn L Wydner,
Deborah B Nixon,
Denise M Visco, Investigator,
Devon Jenkins,
Dhaval H Patel,
Diane M Gubernot,
Dolores Harper,
Doreen P Gubbay,
Doretha M Tonkins,
Doretha M Wilson,
Dylan R Jock,
Edward O'shaughnessy,
Elizabeth E Hart (ASCP), MT,
Emilio Z Azukwu,
Emily A Walters,
Eric J Cunningham,
Eric Zhu,
Erica B Raphael,
Erika M Wilkerson,
Esteban Beltran,
Eufemia G Gonzalez,
Evelyn Taha,
Frank J Marciniak,
Gabriel M Guevarra,
Garrad R Poole,
Gayle J Gehrman,
Gene D Arcy,
Gregory S Larson,
Harry J Brewer,
Helen B Ricalde,
Hitesh R Patel,
Iram R Hassan, PhD,
Irina Gaberman,
Jackson Y See,
Jacqueline S Warner,
James R Birkenstamm,
Jason Kwong,
Jean M Kelahan,
Jennifer A Bazergui,
Jennifer Macmillan,
Jessica L Johnson,
Jessica M Monteiro,
John E Aghadia,
Jonee J Mearns,
Joseph Maselli,
Joy P Matthias,
Juanita P Versace,
Justine Tomasso,
Ka L Wong,
Karen M Labounty,
Kathleen B Swat,
Kelli F Dobilas,
Kellie L Thommes, RN,
Kellie L Westerbuhr,
Kellie Leveille,
Kelly I Anderson,
Kelly L Anderson,
Kimberley A Ricketts,
Kimberly A Coward,
Kip J Hanks,
Kish Bolden,
Kristy A Zielny,
Kwong P Lee,
Kyle D Covill,
Lauren L Vajo,
Leena Thomas,
Li Li,
Lisa Harlan,
Lisa Mathew,
LTJG Matthew R Palo,
Marea K Harmon,
Maria Estrella,
Marla A Cassidy,
Mary E Baker Brown,
Matthew D Schnittker,
Matthew W Kyle,
Melissa A Zuppe,
Melissa D Kalik,
Meredith L Sheridan,
Meredith P Soehl, Investigator,
Michael Serrano,
Michele Gottshall,
Nerizza B Dalena,
Nerizza B Guerin,
Nicholas A Violand,
Nicholas C Mendiola,
Nikisha M Bolden,
Nur M Faisal,
Perez,
Peter M Trunk,
Peter R Caparelli,
Randy L Clarida,
Raymond L Cheung,
Raymond W Brullo,
Regina T Brown,
Remache,
Richard D Manney,
Richard T Riggie,
Robert G Ruff,
Ronald Ifraimov,
Rosia E Nesbitt,
Sandra Kershaw,
Sandra Sejdinovic,
Sarah A Meehan,
Sarah Forney,
Satheesh Thomas,
Shreya Shah,
Stephanie T Durso,
Susan T Hadman,
Suwaskie S Smith,
Taina Pierre Pierre,
Tania Y Hall,
Tara K Carmody,
Tara K Normandin,
Terry E Pierre,
Timothy P Lafave,
Tonia L Sawyer,
Tracy M Portelli,
Valerie A Potopsingh,
Valerie C Reed,
Valerie Jgrecek Trinh,
Valerie Reed,
Wayne J Meyer,
William J Muszynski,
William V Thompson,
Yuyan Liang,
Yvonne C Wilkes
Jennifer L Custodio's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| February, 2019 | FDA 483 | Eversight - Form 483, 2019-02-19 |
| August, 2017 | FDA 483 | Osteotech, Inc. - Form 483, 2017-08-10 |
| July, 2019 | FDA 483 | Center For Advanced Reproductive Medicine & Fertility - Form 483, 2019-07-19 |
| October, 2018 | EIR | SciSafe - EIR, 2018-10-17 |
| July, 2015 | FDA 483 | Valeant Pharmacueticals North America LLC - Form 483, 2015-08-31 |
| March, 2020 | EIR | Laboratory Corporation of America ViroMed Laboratories - EIR, 2020-03-10 |
| January, 2018 | FDA 483 | Musculoskeletal Transplant Foundation, Inc. - Form 483, 2018-01-18 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more